UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000009437 |
|---|---|
| Receipt number | R000011090 |
| Scientific Title | Docetaxel and Trastuzumab therapy or maximal androgen blockade for patients with recurrent and/or metastatic salivary grand carcinoma |
| Date of disclosure of the study information | 2012/12/03 |
| Last modified on | 2019/02/26 19:56:01 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/11/29 18:39:19 | ||
| 2 | Update | 2013/11/26 14:05:42 | Email Last name of contact person Last name of contact person Address TEL |
|
| 3 | Update | 2013/11/26 14:15:38 | Key inclusion criteria Key inclusion criteria |
|
| 4 | Update | 2014/05/29 18:00:45 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 5 | Update | 2016/04/07 17:11:21 | UMIN ID1 |
|
| 6 | Update | 2016/04/07 17:12:46 | Recruitment status |
|
| 7 | Update | 2016/05/31 12:58:54 | Name of primary person or sponsor Organization |
|
| 8 | Update | 2016/12/02 14:39:39 | Key inclusion criteria |
|
| 9 | Update | 2017/12/04 08:45:24 | URL releasing protocol |
|
| 10 | Update | 2018/06/14 14:46:32 | URL releasing protocol |
|
| 11 | Update | 2019/02/26 18:52:50 | Organization Organization Organization Category of Funding Organization |
|
| 12 | Update | 2019/02/26 19:56:01 | Recruitment status URL related to results and publications Results Results Other related information Other related information |
